Eli Lilly, Sanofi Agree To $35 A Month Insulin Price Cap In New York Settlements

Mealey's (May 3, 2023, 7:41 AM EDT) -- NEW YORK — Drugmakers Eli Lilly & Co. and Sanofi-Aventis US LLC have signed settlement agreements with the New York attorney general to cap the price of insulin for diabetics at $35 per month for five years for uninsured New Yorkers and to offer free insulin to low-income patients, the Attorney General’s Office announced May 2....